Trial Details

UNKNOWN
Basic Information
Clinical ID c4299
Identifier NCT00731172
Trial Title A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohns Disease
Interventions DRUG: glatiramer acetate|DRUG: placebo
Participant Information
Sponsor Tel-Aviv Sourasky Medical Center
City Rehovot
Country/Region Israel
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2008-09
Primary Completion Date 2010-07
Completion Date 2011-07